@article{ad08121363214e5d966e46e663b62aeb,
title = "Reply: Redo-TAVR May Not Always Be an Option",
author = "Uri Landes and Janarthanan Sathananthan and David Wood and Webb, {John G.}",
note = "Funding Information: Please note: Drs. Webb and Wood are consultants for and have received research funding from Edwards Lifesciences, Abbott Vascular, Boston Scientific, and ViVitro Labs. Dr. Sathananthan is a consultant for Edwards Lifesciences. Dr. Landes has reported that he has no relationships relevant to the contents of this paper to disclose. Vinod H. Thourani, MD, served as Guest Associate Editor for this paper. Deepak L. Bhatt, MD, MPH, served as Guest Editor-in-Chief for this paper. ",
year = "2020",
month = aug,
day = "25",
doi = "10.1016/j.jacc.2020.06.047",
language = "אנגלית",
volume = "76",
pages = "1004--1005",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "8",
}